Free tool

Oncology stocks

We cover 15 companies grouped under the Oncology theme. The median market value in the group is $4.34M. Across the group, the median move over the past trading day is −2.77%. Price change over the past year runs from −98.1% to −65.3% across the middle 80 percent of the group, with a median of −82.6%.

Other lists in this group

Table

15 of 319 companies match these filters.Clear filters

TickerCompanyPrice1M returnYTD return1Y return
0J4V.LHeron Therapeutics, Inc.$0.31−3.55%−76.14%−78.12%
KPTIKaryopharm Therapeutics Inc. Common Stock$1.96−72.36%−72.74%−74.90%
IMU.AXImugene Limited0.07 AUD−17.65%−82.05%−75.00%
ABVCABVC BioPharma, Inc.$0.71−32.92%−67.53%−76.14%
RADXRadiopharm Theranostics Limited$2.32−29.91%−55.04%−58.87%
PDSBPDS Biotechnology Corporation$0.22−67.70%−73.21%−82.56%
MBRXMoleculin Biotech, Inc.$0.60−72.60%−83.43%−96.05%
APVOAptevo Therapeutics Inc.$2.41−42.76%−74.33%−92.52%
CRISCuris, Inc.$1.54−68.12%+57.14%−5.52%
RNAZTransCode Therapeutics, Inc.$2.34−53.20%−68.38%−76.72%
0RK9.LAlligator Bioscience AB (publ)0.03 SEK+10.16%−90.40%−99.13%
SLXNSilexion Therapeutics Corp$0.35−85.51%−81.12%−95.11%
DCOYDecoy Therapeutics Inc.$3.01−25.50%−61.53%−95.78%
ATORX.STAlligator Bioscience AB (publ)0.03 SEK−32.46%−91.74%−99.27%
BDRXBiodexa Pharmaceuticals Plc$0.98−32.13%−92.05%−96.58%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse